Biographical Sketch
Andre Machado, MD, PhD, is Associate Staff in the Department of Center for Neurological Restoration, the Department of Neurosciences, the Department of Biomedical Engineering and Department of Neurological Surgery, all located at Cleveland Clinic's main campus.
Dr. Machado earned a doctorate in medicine and a PhD in experimental neurology from the University of Sao Paulo in Sao Paulo, Brazil. He then completed a neurology internship and residency at the same institution. Dr. Machado also completed a fellowship at the Cleveland Clinic in stereotactic and functional neurosurgery.
As principal investigator of a National Institutes of Health (NIH) study, Dr. Machado is investigating the use of cerebellar stimulation to induce recovery of motor skills following stroke. The central hypothesis is that stimulation of this pathway will increase the excitability of the cortical areas, facilitate plastic reorganization and improve motor outcomes. Prior to that, Dr. Machado was co-investigator of a NIH study to assess the safety of using MRIs for deep brain stimulation.
Dr. Machado has published his research in many peer-reviewed journals. In 2006, the American Association of Neurological Surgeons (Stereotactic and Functional Neurosurgery Section) awarded Dr. Machado the Philip L. Guildenberg Award for published research, determining the optimal cathode location for deep brain stimulation as a treatment for refractory obsessive-compulsive disorder. He was a co-author of a 2007 Nature article titled “Behavioral improvements with thalamic stimulation after severe traumatic brain injury.”
Dr. Machado was recently awarded a Cleveland Clinic’s Innovator Award.
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/1/2008, Dr.
Machado has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Machado receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Codman & Shurtleff, Inc.
IntElect Medical Inc.
Inventor Share. Dr. Machado may receive future financial benefits from the Cleveland Clinic for inventions or discoveries related to the companies shown below:
Autonomic Technologies
IntElect Medical Inc.
Cardionomic, Inc.
Equity. Dr. Machado owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
IntElect Medical Inc.
